BPC-157
Used as part of clinician-guided planning for tendon, ligament, connective-tissue, soft-tissue, joint, and gut-related recovery goals.
Back to peptide library
Synergistic recovery blend
BPC / TB-5
A BPC-157 and TB-500 blend used as part of clinician-guided planning for localized tissue recovery support, broader systemic recovery capacity, connective-tissue goals, training irritation, and clinician-guided return-to-performance planning.
2 peptide blendBPC local supportTB-500 systemic supportClinical review required
Overview
What is BPC / TB-5?
BPC / TB-5 refers to a blend of BPC-157 and TB-500. BPC-157 is framed around localized tissue recovery, tendon and ligament support, soft-tissue goals, and gut-related recovery context. TB-500 is framed around systemic recovery support, cell mobility, tissue remodeling, and whole-body recovery capacity.
IPS evaluates this blend alongside the actual problem being addressed: injury history, training load, joint or connective-tissue concerns, gut symptoms, current rehab, medications, and whether a different medical evaluation is needed first.
Common program goals
- Support training recovery and soft-tissue resilience
- Review tendon, ligament, joint, muscle, or connective-tissue goals
- Pair peptide support with rehab and progressive loading
- Review gut and inflammatory-balance context when relevant
- Track function, pain, tolerance, and response over time
Who it may fit
Clinical BPC / TB-5 consideration.
TB-500
Used as part of clinician-guided planning for tissue remodeling, cellular mobility, mobility support, and broader recovery capacity.
Recovery plan fit
Considered alongside diagnosis, rehab quality, progressive loading, sleep, nutrition, and clinician follow-up.
How It Works
Why combine BPC-157 and TB-500?
The blend is commonly paired because BPC-157 and TB-500 are framed as complementary recovery-support peptides. IPS keeps claims cautious and ties the review to rehab quality, training decisions, nutrition, sleep, and medical context.
BPC-157 role
Supports localized recovery information involving tendons, ligaments, joints, soft tissue, connective tissue, and gastrointestinal context.
TB-500 role
Supports broader recovery information involving tissue remodeling, cell migration, mobility, and whole-body recovery capacity.
Why pair them?
BPC-157 and TB-500 are paired because they support different recovery lanes: local tissue concerns and systemic remodeling support.
Clinical foundation
This belongs inside a care plan that considers diagnosis, imaging when needed, rehab, progressive loading, nutrition, sleep, and follow-up.
Process
How BPC / TB-5 care works at IPS.
Consultation
Review injury history, training load, pain/function goals, gut concerns, medications, and current care plan.
Assessment
Clarify whether symptoms require medical evaluation, imaging, rehab referral, or lab review before peptide review.
Protocol Design
If appropriate, your clinician reviews who it may fit, expectations, monitoring, and follow-up.
Progress Review
Follow-up evaluates tolerance, recovery markers, function, training response, and whether the plan should change.
Safety & candidacy
BPC / TB-5 requires medical review.
IPS reviews health history, active diagnoses, cancer history, pregnancy-related factors where applicable, current medications, injury status, and whether more urgent medical evaluation is needed before considering this blend.
Common effectsInjection-site irritation, headache, fatigue, nausea, or tolerance changes may occur.
ScreeningPersistent pain, acute injury, infection, neurologic symptoms, or post-surgical issues may need direct evaluation first.
MonitoringFollow-up should track symptoms, function, training response, side effects, and whether the plan remains appropriate.
AthletesCompetitive athletes should check their governing body's rules before using peptide therapies.
Questions
Frequently asked.
How is this different from BPC-157 alone?
BPC / TB-5 adds TB-500 to BPC-157, so the information shifts from a single recovery peptide to a blend intended for broader recovery-support goals.
What goals is it usually used as part of clinician-guided planning for?
Connective tissue, joint irritation, training recovery, soft tissue, mobility, and broader injury-recovery information are common themes.
Can this replace rehab?
No. It should be considered, if appropriate, alongside diagnosis, rehab, progressive loading, nutrition, and sleep.
How does IPS evaluate this exact blend?
IPS reviews clinical goals, health history, and safety factors before considering whether this option fits the care plan.
Why IPS is different
Not gray market. Not research-only. Not direct-to-consumer peptide kits.
Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.
RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS
Products marketed online
- May be labeled research use only
- May be labeled not for human consumption
- May be marketed as laboratory chemicals
- May not include patient-specific documentation
- May not involve provider review
The IPS approach
- Consultation before recommendation
- Provider review
- Personalized recommendations
- Medical oversight
- Ongoing guidance and support
Important distinction
A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.
Annual Membership
Wholesale-Style Member Pricing
12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.
12-month membership requiredMember pricing reviewed during consultClinical review before any plan
Ask About Membership PricingContact
Ask IPS about BPC / TB-5 eligibility.
Send your details and IPS can follow up about consultation scheduling and next steps.
Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Peptide decisions require qualified clinical care.